TrialJournal of pain research2020

Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study.

Mamoru Shibata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.